Skip to main content
. 2017 Jan 11;9:9–17. doi: 10.2147/CPAA.S119676

Table 1.

Plasma dronabinol pharmacokinetics for dronabinol oral solution 4.25 mg under fed conditions and dronabinol capsule 5 mg under fed or fasted conditions

Parameter Dronabinol oral solution 4.25 mg (fed state)
Dronabinol capsule 5 mg (fed state)
Dronabinol capsule 5 mg (fasted state)
Mean (SD) CV (%) Mean (SD) CV (%) Mean (SD) CV (%)
Tlag (hour) 0.15 (0.07)a 49.30a 2.02 (1.42)b 70.19b 0.52 (0.55)c 105.17c
Tmax (hour) 7.67 (3.43)a 44.74a 5.59 (3.24)b 57.96b 1.73 (1.74)c 100.82c
Cmax (ng/mL) 1.52 (0.97)a 63.52a 2.60 (1.74)b 67.11b 2.19 (1.06)c 48.51c
AUC0−t (hour × ng/mL) 9.10 (3.84)a 42.20a 10.47 (4.85)b 46.29b 4.44 (2.67)c 60.17c
AUC0−∞ (hour × ng/mL) 10.25 (3.78)d 36.87d 12.21 (4.83)e 39.61e 4.33 (2.49)f 57.52f
t1/2 (hour) 9.35 (6.73)d 71.91d 10.41 (9.24)e 88.72e 4.82 (5.85)f 121.40f

Notes:

a

n=52;

b

n=54;

c

n=53;

d

n=30;

e

n=35;

f

n=47.

Abbreviations: AUC0−∞, area under the plasma concentration–time curve from time zero to infinity; AUC0−t, area under the plasma concentration–time curve from time zero to the last measurable concentration; Cmax, maximum plasma concentration; CV, coefficient of variation; SD, standard deviation; t1/2, half-life; Tlag, time to the first measurable concentration; Tmax, time to maximum plasma concentration.

HHS Vulnerability Disclosure